Chengda Pharmaceutical announced that shareholders holding more than 5%, Shenzhen Qianhai Shengtai Investment Enterprise, plan to reduce their company shares by up to 6.3849 million shares in bulk transactions within 3 months after 15 trading days from the disclosure date of the announcement, accounting for 4.22% of the total share capital excluding the repurchased shares. This shareholding reduction is due to the shareholder's own operational needs, not exceeding 4.22% of its total shares. The reduction price will be determined based on market prices.